Aurinia Pharmaceuticals, Inc. (AUPH)
16.58
-0.07
(-0.42%)
USD |
NASDAQ |
Aug 24, 16:00
16.58
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals Market Cap : 2.204B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 2.213B |
| August 20, 2026 | 2.295B |
| August 19, 2026 | 2.149B |
| August 18, 2026 | 2.033B |
| August 17, 2026 | 2.032B |
| August 14, 2026 | 2.056B |
| August 13, 2026 | 2.018B |
| August 12, 2026 | 2.053B |
| August 11, 2026 | 2.043B |
| August 10, 2026 | 2.053B |
| August 07, 2026 | 2.107B |
| August 06, 2026 | 2.144B |
| August 05, 2026 | 2.019B |
| August 04, 2026 | 1.984B |
| August 03, 2026 | 1.905B |
| July 31, 2026 | 1.946B |
| July 30, 2026 | 1.962B |
| July 29, 2026 | 1.985B |
| July 28, 2026 | 1.956B |
| July 27, 2026 | 1.990B |
| July 24, 2026 | 2.007B |
| July 23, 2026 | 1.993B |
| July 22, 2026 | 2.005B |
| July 21, 2026 | 2.045B |
| July 20, 2026 | 1.994B |
| Date | Value |
|---|---|
| July 17, 2026 | 2.087B |
| July 16, 2026 | 2.084B |
| July 15, 2026 | 2.105B |
| July 14, 2026 | 2.090B |
| July 13, 2026 | 2.096B |
| July 10, 2026 | 2.064B |
| July 09, 2026 | 2.169B |
| July 08, 2026 | 2.122B |
| July 07, 2026 | 2.121B |
| July 06, 2026 | 2.026B |
| July 02, 2026 | 2.041B |
| July 01, 2026 | 2.066B |
| June 30, 2026 | 2.219B |
| June 29, 2026 | 2.196B |
| June 26, 2026 | 2.253B |
| June 25, 2026 | 2.295B |
| June 24, 2026 | 2.435B |
| June 23, 2026 | 2.338B |
| June 22, 2026 | 2.292B |
| June 18, 2026 | 2.152B |
| June 17, 2026 | 2.111B |
| June 16, 2026 | 2.121B |
| June 15, 2026 | 2.092B |
| June 12, 2026 | 2.069B |
| June 11, 2026 | 2.073B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| enGene Therapeutics, Inc. | 121.25M |
| Medicus Pharma Ltd. | 15.64M |
| Sirona Biochem Corp. | 1.320M |
| Xenon Pharmaceuticals, Inc. | 5.857B |
| Psyence Biomedical Ltd. | 9.632M |
Market Cap Related Metrics
| PE Ratio | 7.248 |
| PS Ratio | 7.256 |
| PEG Ratio | 0.0166 |
| Price to Book Value | 3.584 |
| Price to Free Cash Flow | 12.98 |
| Price | 16.58 |
| Earnings Yield | 13.80% |
| PEGY Ratio | 0.0166 |
| Operating PE Ratio | 16.07 |
| Normalized PE Ratio | 7.248 |